Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised KKR in connection with the acquisition of Gunnebo Industrier
Mandate

Vinge has advised KKR in connection with the acquisition of Gunnebo Industrier

May 22, 2019 M&A

Vinge has advised the global investment company, KKR in connection with the acquisition by its portfolio company Crosby of Gunnebo Industrier from Segulah and minority investors.

Crosby is a global, market‑leading company with products within lifting and rigging. Gunnebo Industrier is an international manufacturing group that provides lifting and material handling products to a global customer base. The company was founded in 1764 and has manufacturing units in Sweden, Norway and the USA with subsidiaries in nine countries and distribution partners in more than 50 countries.

Vinge’s team consisted of, among others, Christina Kokko, Samra Baytar, Marith Welin-Berger and Hanna Risberg (Corporate and M&A), Adriana Berglund and Michael Montner (Commercial Agreements), Lisa Ullman (Employment), André Isacson and Josefine Larsson (Banking and Finance), Klara Secher and Hannah Kajlinger (IP), Kristoffer Larson (Real Property), Agnes Perbo and Nicklas Thorgerzon (IT) and Jessica Öijer (VDR assistant).

Related

Vinge advises Sobro on its investment in Västkustens Konstruktionsbyrå

 Västkustens Konstruktionsbyrå has decided to broaden its ownership structure by bringing in Sobro as a new co-partner and majority shareholder. The founders will remain with the company as the CEO and CTO respectively, and as significant shareholders. Västkustens Konstruktionsbyrå is an engineering consultancy company based in Gothenburg with cutting-edge expertise in project management, civil engineering and design.
April 23, 2026

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of SEK 350 million before transaction costs.
April 22, 2026

Vinge has advised Alder on the establishment of Alder Strategic Opportunities Fund I and on a fund credit facility agreement in connection with the fundraising

 Vinge has advised Alder on the establishment of the continuation fund Alder Strategic Opportunities Fund I AB. In connection with the establishment, the fund acquires the portfolio companies SI and SMG from Alder II. Vinge also advised Alder on the entering into of a fund credit facility agreement with SEB.
April 20, 2026